Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 100 Professional Dr, Reidsville, NC 27320 Phone: 336-342-3336 Fax: 336-342-3226 |
Dr. Harold L Jennings Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1203 Northup St, Reidsville, NC 27320 Phone: 336-342-3159 Fax: 336-349-2277 |
Professional Vision Care, Od, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1624 Nc #14 Highway, Reidsville, NC 27320 Phone: 336-349-2270 |
Dr. Mark Christopher Cotter, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 100 Professional Dr, Reidsville, NC 27320 Phone: 336-342-3336 Fax: 336-342-3226 |
Myeyedr Optometrist Medicare: Not Enrolled in Medicare Practice Location: 100 Professional Dr, Reidsville, NC 27320 Phone: 336-342-3336 Fax: 336-342-3226 |
Harold L Jennings, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1203 Northup St, Reidsville, NC 27320 Phone: 336-342-3159 Fax: 336-349-2277 |
News Archive
The genomes of cancer cells-cells that do not obey signals to stop reproducing-are riddled with genetic mutations, causing them inadvertently to make many dysfunctional proteins.
Girls are stronger with higher levels of vitamin D, but the association was not found in boys. These are the results from a new large study from the Odense Child Cohort, recently published in the Journal of Clinical Endocrinology and Metabolism.
Watson Pharmaceuticals, Inc. announced that its subsidiary, Watson Laboratories, Inc. has received tentative approval today from the United States (U.S.) Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Fentanyl Citrate Buccal tablets, 100 mcg, 200 mcg, 300 mcg, 400 mcg, 600 mcg and 800 mcg.
Research from the National Association on Mental Health suggests that one in five Americans experiences a mental illness in a given year. The same research shows that African Americans and Hispanic Americans used mental health services at about one-half the rate of Caucasian Americans and Asian Americans at about one-third the rate.
Research from Western University (London, Canada) has revealed a possible new target for treating movement disorders such as Huntington's disease (HD) and Parkinson's disease. Stephen Ferguson, PhD, a scientist at Western's Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviors in a HD mouse model when one of the major neurotransmitters in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted.
› Verified 7 days ago